Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 2001 Mar;45(3):660–663. doi: 10.1128/AAC.45.3.660-663.2001

Standard Numbering Scheme for Class B β-Lactamases

Moreno Galleni 1,*, Josette Lamotte-Brasseur 1, Gian Maria Rossolini 2, Jim Spencer 3, Otto Dideberg 4, Jean-Marie Frère 1; The Metallo-β-Lactamase Working Group
PMCID: PMC90352  PMID: 11181339

Metallo-β-lactamases constitute the molecular class B of Ambler (1) and group 3 according to the Bush-Jacoby-Medeiros functional classification (6). In recent years, many new enzymes of this class have been described and the sequences of the corresponding genes have been determined. Their clinical importance is highlighted by the fact that they hydrolyze carbapenems, compounds which most often escape the activity of active-site serine β-lactamases. Moreover, most metallo-β-lactamases are broad-spectrum enzymes which also hydrolyze a variety of penicillins and cephalosporins (13, 21, 22, 26). On the basis of the known sequences, three different lineages, identified as subclasses B1, B2, and B3, can be characterized. Subclass B1 contains most known metallo-β-lactamases, including the β-lactamase II (BcII) proteins from Bacillus cereus or other Bacillus spp. (15, 16, 19) and Bacillus sp. strain 170 (16), the CcrA (24) (also named CfiA [29]) proteins of Bacteroides fragilis, the BlaB proteins from Chryseobacterium meningosepticum (2, 26, 34), the IND-1 enzyme from Chryseobacterium indologenes (3), the IMP proteins found in some clinical isolates of Pseudomonas aeruginosa (17, 28), Serratia marcescens (21), Klebsiella pneumoniae (GenBank EMBL accession no. D29636), and Acinetobacter baumannii (25), and the VIM proteins found in some P. aeruginosa clinical isolates (18, 22). Subclass B2 includes the enzymes produced by various species of Aeromonas (CphA [20], ImiS [33], and CphA2 [23]) and the Sfh-I β-lactamase (GenBank accession no. AF197943) from Serratia fonticola. Finally, subclass B3 includes the L1 proteins from Stenotrophomonas maltophilia (27, 32), the GOB proteins from C. meningosepticum (2), the FEZ-1 enzyme from Legionella gormanii (5), and the THIN-B β-lactamase produced by Janthinobacterium lividum (25a).

The three-dimensional structures of several B1 (BcII [7, 9, 12], CcrA [8, 10], and IMP-1 [11]) enzymes and one B3 (L1 [31]) enzyme have been solved by X-ray crystallography. Despite a very low degree of sequence similarity between the two subclasses, the general structures and the relative positions of the secondary structure elements are similar. Surprisingly, the L1 enzyme is a tetramer (4, 31), whereas the B1, B2, and other B3 (FEZ-1 [5; P. S. Mercuri, F. Bouillenne, L. Boschi, J. Lamotte-Brasseur, G. Amicosante, B. Devreese, J. van Beeumen, J. M. Frère, G. M. Rossolini, and M. Galleni, unpublished data] and GOB-1 [2]) β-lactamases so far studied are monomers.

There are, however, no doubts that the proteins are homologous and the sequences of representatives of the three subclasses can be easily aligned. Indeed, in addition to the expected differences at the N and C termini, several insertions and deletions are necessary to allow the alignment of the few conserved residues acting, for instance, as ligands of the two zinc ions which can bind at the active site. Thus, homologous residues from the different class B sequences which are known to play a relevant role in the structure and function often differ in their numbering, even within each subclass.

In order to facilitate the comparative analysis of the structures and of the catalytic mechanisms, we would like to propose a standard numbering scheme for the class B β-lactamases, the BBL numbering, by analogy with the ABL numbering which has been widely accepted for class A β-lactamases. For the class B enzymes, the task was complicated by insertions and deletions and by the generally low degree of similarity but facilitated by the availability of some three-dimensional structures, which allowed the identification of homologous secondary structure elements, even when the sequence similarity was not obvious.

Figure 1 shows the proposed alignment and the derived numbering. The observed (B1 and B3) and expected (B2) secondary structure elements are indicated.

FIG. 1.

FIG. 1

Alignment of 12 class B β-lactamases numbered according to the BBL scheme. The sequences are referred to by their familiar names. BcII, Bacillus cereus 569H (15); IMP-1, Pseudomonas aeruginosa 101/477 (17); CcrA, Bacteroides fragilis TAL3636 (24); VIM-1, Pseudomonas aeruginosa VR-143/97 (18); BlaB, Chryseobacterium meningosepticum NCTC10585 (26); IND-1, Chryseobacterium indologenes 001 (3); CphA, Aeromonas hydrophila AE036 (20); Sfh-I, Serratia fonticola UTAD54 (GenBank accession no. AF197943); L1, Stenotrophomonas maltophilia IID1275 (32); FEZ-1, Legionella gormanii ATCC33297T (5); GOB-1, Chryseobacterium meningosepticum PINT (2); and THIN-B, Janthinobacterium lividum JAC1 (25a). The names written in bold refer to the enzymes for which the three-dimensional structure is known. The amino acid in bold (Ala 22 of L1) represents the first amino acid of the mature β-lactamase. Conserved secondary structure elements of subclasses B1 and B3 are indicated above the sequences: 310, 310 helix; S, β strand; H, helix. Secondary structure elements specific to subclasses B1 and B3 are highlighted by italic characters above and under the sequences, respectively. Amino acid insertions in newly sequenced enzymes are represented by small letters. The residues acting as zinc ligands in at least one subclass are characterized as follows: z, conserved residues in the three subclasses; ·, conserved residues in subclass B1 and some enzymes of subclass B3; +, conserved residue in subclass B3; §, conserved residues in subclasses B1 and B2.

The following comments can be made. (i) Not all the known sequences are shown. When variants of an enzyme are known and the amino acid alignment exhibits more than 80% sequence identity, only the first described sequence is included in the alignment.

(ii) Alignments at the N and C termini are rather uncertain, due to a high variability even within each subclass. As is done for the class A enzymes, residue no. 1 is the first residue of the leader peptide sequence of the S. maltophilia L1 protein (32). Since they are highly divergent and irrelevant to the functional structure, the other leader sequences have not been included unless the site of action of the signal peptidase has not been verified (Sfh-I [GenBank accession no. AF197943], IND-1 [3], and THIN-B [25a]).

(iii) This is only a numbering scheme. The fact that residues in different proteins have been assigned the same number does not imply that they occupy exactly the same relative spatial position. Indeed, if the Zn ions and their ligands are superimposed, the G232N233 dyad of BcII is more than 3 Å away from the corresponding residues in the S. maltophilia enzyme.

(iv) The loop which can close the active site of B1 enzymes extends between residues BBL 61 and 65 (11, 14, 30). It is absent in subclass B3 (31) and probably in B2.

(v) Any insert in a newly discovered enzyme can be characterized by small letters following the number of the last residue of the consensus sequence. Accordingly, residues N140G141 of THIN-B are defined as BBL 150a and -b and residues I198EQG201 of Sfh-I are defined as BBL 252a, -b, -c and -d, respectively.

(vi) Table 1 shows a cross-reference of the BBL numbering of the residues identified as or suspected to be the Zn1 and Zn2 ligands and that used for the individual enzymes up to the present time. Note that in subgroup B3, one of the Zn2 ligands (H121) originates with a very different part of the polypeptide chain compared to subgroup B1. Similarly, in subclass B2 and for the B3 GOB-1 enzyme, the sequence alignments unambiguously point to residues H118, H196, and N116 (B2) or Q116 (B3), but such a function is rather unusual for asparagine and glutamine side chains.

TABLE 1.

Numbering of the important class B residuesa

β-Lactamase Zn1 ligands Zn2 ligands
Subclass B1
Consensus BBL His116 His118 His196 Asp120 Cys221 His263
 BcII His86 His88 His149 Asp90 Cys168 His210
 IMP-1 His77 His79 His139 Asp81 Cys158 His197
 CcrA His99 His101 His162 Asp 103 Cys181 His223
VIM-1 His88 His90 His153 Asp92 Cys172 His214
BlaB His76 His78 His139 Asp80 Cys158 His200
IND-1 His96 His98 His159 Asp100 Cys178 His220
Subclass B2
Consensus BBL Asn116 His118 His196 Asp120 Cys221 His263
CphA Asn69 His71 His148 Asp73 Cys167 His205
Sfh-I Asn72 His74 His151 Asp76 Cys170 His212
Subclass B3
Consensus BBL His/Gln116 His118 His196 Asp120 His121 His263
 L1 His84 His86 His160 Asp88 His89 His225
FEZ-1 His71 His73 His149 Asp75 His76 His215
GOB-1 Gln80 His82 His157 Asp84 His85 His213
THIN-B His105 His107 His185 Asp109 His110 His253
a

For CcrA, the numbering is reported in references 10 and 24. When not confirmed by a three-dimensional structure, the ligands are underlined. The consensus (bold) and putative consensus (bold and underlined) ligand numbers are given for each subgroup. 

ACKNOWLEDGMENTS

This work was supported in part by a grant from the European Union (grant ERB3512-IC15-CT98-0914) as part of the training and mobility of researchers program and by the Belgian Program Pôles d'Attraction Interuniversitaire initiated by the Belgian state, prime minister's office, Services Fédéraux des Affaires Economiques, Techniques et Culturelles (PAI P4/03).

Appendix

The metallo-β-lactamase group also includes the following: G. Amicosante and N. Franceschini, Dipartimento di Scienze e Tecnologie Biomediche, Università di L'Aquila, I-67100 Coppito, L'Aquila, Italy; K. Bush, The R. W. Johnson Pharmaceutical Research Institute, Raritan, NJ 08869; N. O. Concha, Department of Structural Biology, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406; O. Herzberg, Center for Advanced Research in Biotechnology, University of Maryland Biotechnology Institute, Rockville, MD 20850; D. M. Livermore, Antibiotic Resistance Monitoring and Reference Laboratory, Central Public Health Laboratory, London NW9 5HT, United Kingdom; P. Nordmann, Service de Bactériologie-Virologie, Hopital de Bicêtre, Faculté de Médecine Paris-Sud, 94275 Le Kremlin-Bicêtre, France; B. A. Rasmussen, Wyeth-Ayerst Research, Pearl River, NY 10965; J. Rodrigues and M. J. Saavedra, Department of Animal Health, University of Trás-os-Montes e Alto Douro, 5000-911 Vila Real, Portugal; B. Sutton and S. M. Fabiane, The Randall Centre, King's College London, London SE1 1UL, United Kingdom; and J. H. Toney, Department of Biochemistry, Merck Research Laboratories, Rahway, NJ 07065-0900.

REFERENCES

  • 1.Ambler R P. The structure of beta-lactamase. Philos Trans R Soc B Biol Sci. 1980;289:321–331. doi: 10.1098/rstb.1980.0049. [DOI] [PubMed] [Google Scholar]
  • 2.Bellais S, Aubert D, Naas T, Nordmann P. Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing β-lactamases in Chryseobacterium meningosepticum. Antimicrob Agents Chemother. 2000;44:1878–1886. doi: 10.1128/aac.44.7.1878-1886.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Bellais S, Leotard S, Poirel L, Naas T, Nordmann P. Molecular characterization of a carbapenem-hydrolyzing beta-lactamase from Chryseobacterium (Flavobacterium) indologenes. FEMS Microbiol Lett. 1999;171:127–132. doi: 10.1111/j.1574-6968.1999.tb13422.x. [DOI] [PubMed] [Google Scholar]
  • 4.Bicknell R, Emanuel E L, Gagnon J, Waley S G. The production and molecular properties of the zinc beta-lactamase of Pseudomonas maltophilia IID 1275. Biochem J. 1985;229:791–797. doi: 10.1042/bj2290791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Boschi L, Mercuri P S, Riccio M L, Amicosante G, Galleni M, Frère J-M, Rossolini G M. The Legionella (Fluoribacter) gormanii metallo-β-lactamase: a new member of the highly divergent lineage of molecular-subclass B3 β-lactamase. Antimicrob Agents Chemother. 2000;44:1538–1543. doi: 10.1128/aac.44.6.1538-1543.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bush K, Jacoby G, Medeiros A A. A functional classification for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995;39:1211–1233. doi: 10.1128/aac.39.6.1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Carfi A, Duée E, Galleni M, Frére J M, Dideberg O. 1.85 Å resolution structure of the zinc (II) β-lactamase from B. cereus. Acta Crystallogr Sect D. 1998;54:313–323. doi: 10.1107/s0907444997010627. [DOI] [PubMed] [Google Scholar]
  • 8.Carfi A, Duée E, Paul-Soto R, Galleni M, Frère J M, Dideberg O. X-ray structure of the ZnII beta-lactamase from Bacteroides fragilis in an orthorhombic crystal form. Acta Crystallogr Sect D. 1998;54:45–57. doi: 10.1107/s090744499700927x. [DOI] [PubMed] [Google Scholar]
  • 9.Carfi A, Pares S, Duée E, Galleni M, Duez C, Frère J M, Dideberg O. The 3D structure of a zinc metallo-β-lactamase from Bacillus cereus reveals a new type of protein fold. EMBO J. 1995;14:4914–4921. doi: 10.1002/j.1460-2075.1995.tb00174.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Concha N O, Rasmussen B A, Bush K, Herzberg O. Crystal structure of the wide-spectrum binuclear zinc β-lactamase from Bacteroides fragilis. Structure. 1996;4:823–836. doi: 10.1016/s0969-2126(96)00089-5. [DOI] [PubMed] [Google Scholar]
  • 11.Concha N O, Janson C A, Rowling P, Pearson S, Cheever C A, Clarke B P, Lewis C, Galleni M, Frere J M, Payne D J, Bateson J H, Abdel-Meguid S S. Crystal structure of the IMP-1 metallo beta-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor. Biochemistry. 2000;39:4288–4298. doi: 10.1021/bi992569m. [DOI] [PubMed] [Google Scholar]
  • 12.Fabiane S M, Sohi M K, Wan T, Payne D J, Bateson J H, Mitchell T, Sutton B J. Crystal structure of the zinc-dependent beta-lactamase from Bacillus cereus at 1.9 Å resolution: binuclear active site with features of a mononuclear enzyme. Biochemistry. 1998;37:12404–12411. doi: 10.1021/bi980506i. [DOI] [PubMed] [Google Scholar]
  • 13.Felici A, Amicosante G, Oratore A, Strom R, Ledent P, Joris B, Fanuel L, Frère J M. An overview of the kinetic parameters of class B β-lactamases. Biochem J. 1993;291:151–155. doi: 10.1042/bj2910151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Fitzgerald P M, Wu J K, Toney J H. Unanticipated inhibition of the metallo-beta-lactamase from Bacteroides fragilis by 4-morpholineethanesulfonic acid (MES): a crystallographic study at 1.85 Å resolution. Biochemistry. 1998;37:6791–6800. doi: 10.1021/bi9730339. [DOI] [PubMed] [Google Scholar]
  • 15.Hussain M, Carlino A, Madonna M J, Lampen O. Cloning and sequencing of the metallothioprotein β-lactamase II gene of Bacillus cereus 569H in Escherichia coli. J Bacteriol. 1985;164:223–229. doi: 10.1128/jb.164.1.223-229.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kato C, Kudo T, Watanabe K, Horikoshi K. Nucleotide sequence of the beta-lactamase gene of alkalophilic Bacillus sp. strain 170. J Gen Microbiol. 1985;131:3317–3324. doi: 10.1099/00221287-131-12-3317. [DOI] [PubMed] [Google Scholar]
  • 17.Laraki N, Galleni M, Thamm I, Riccio M L, Amicosante G, Frère J M, Rossolini G M. Structure of In31, a blaIMP-containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual array of gene cassettes. Antimicrob Agents Chemother. 1999;43:890–901. doi: 10.1128/aac.43.4.890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Lauretti L, Riccio M L, Mazzariol A, Cornaglia G, Amicosante G, Fontana R, Rossolini G M. Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother. 1999;43:1584–1590. doi: 10.1128/aac.43.7.1584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Lim H M, Pene J J, Shaw R W. Cloning, nucleotide sequence, and expression of the Bacillus cereus 5/B/6 beta-lactamase II structural gene. J Bacteriol. 1988;170:2873–2878. doi: 10.1128/jb.170.6.2873-2878.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Massida O, Rossolini G M, Satta G. The Aeromonas hydrophila cphA gene: molecular heterogeneity among class B metallo-β-lactamases. J Bacteriol. 1991;173:4611–4617. doi: 10.1128/jb.173.15.4611-4617.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Osano E, Arakawa Y, Wacharotayankun R, Ohta M, Horii T, Ito H, Yoshimura F, Kato N. Molecular characterization of an enterobacterial metallo-β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother. 1994;38:71–78. doi: 10.1128/aac.38.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo J-D, Nordmann P. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 2000;44:891–897. doi: 10.1128/aac.44.4.891-897.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Rasmussen B A, Bush K. Carbapenem-hydrolyzing β-lactamases. Antimicrob Agents Chemother. 1997;41:223–232. doi: 10.1128/aac.41.2.223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Rasmussen B A, Gluzman Y, Tally F P. Cloning and sequencing of the class B beta-lactamase gene (ccrA) from Bacteroides fragilis TAL3636. Antimicrob Agents Chemother. 1990;34:1590–1592. doi: 10.1128/aac.34.8.1590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Riccio M L, Franceschini N, Boschi L, Caravelli B, Cornaglia G, Fontana R, Amicosante G, Rossolini G M. Characterization of the metallo-beta-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of bla(IMP) allele variants carried by gene cassettes of different phylogeny. Antimicrob Agents Chemother. 2000;44:1229–1235. doi: 10.1128/aac.44.5.1229-1235.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25a.Rossolini G M, Condemi A, Pantanella F, Docquier J-D, Amicosante G, Thaller M C. Metallo-β-lactamase producers in environmental microbiota: new molecular class B enzyme in Janthinobacterium lividum. Antimicrob Agents Chemother. 2001;45:836–843. doi: 10.1128/AAC.45.3.837-844.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Rossolini G M, Franceschini N, Riccio M L, Mercuri P S, Perilli M, Galleni M, Frère J M, Amicosante G. Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B beta-lactamase showing a broad substrate profile. Biochem J. 1998;332:145–152. doi: 10.1042/bj3320145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Sanchagrin F, Dufresne J, Levesque R C. Molecular heterogeneity of the L-1 metallo-β-lactamase family from Stenotrophomonas maltophilia. Antimicrob Agents Chemother. 1998;42:1245–1248. doi: 10.1128/aac.42.5.1245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Senda K, Arakawa Y, Nakashima K, Ito H, Ichiyama S, Shimokata K, Kato N, Ohta M. Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems. Antimicrob Agents Chemother. 1996;40:349–353. doi: 10.1128/aac.40.2.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Thompson J S, Malamy M H. Sequencing the gene for an imipenem-cefoxitin-hydrolyzing enzyme (CfiA) from Bacteroides fragilis TAL2480 reveals strong similarity between CfiA and Bacillus cereus beta-lactamase II. J Bacteriol. 1990;172:2584–2593. doi: 10.1128/jb.172.5.2584-2593.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Toney J H, Fitzgerald P M, Grover-Sharma N, Olson S H, May W J, Sundelof J G, Vanderwall D E, Cleary K A, Grant S K, Wu J K, Kozarich J W, Pompliano D L, Hammond G G. Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-beta-lactamase. Chem Biol. 1998;5:185–196. doi: 10.1016/s1074-5521(98)90632-9. [DOI] [PubMed] [Google Scholar]
  • 31.Ullah J H, Walsh T R, Taylor I A, Emery D C, Verma C S, Gamblin S J, Spencer J. The crystal structure of the L1 metallo-β-lactamase from Stenotrophomonas maltophilia at 1.7 Å resolution. J Mol Biol. 1998;284:125–136. doi: 10.1006/jmbi.1998.2148. [DOI] [PubMed] [Google Scholar]
  • 32.Walsh T R, Hall L, Assinda S J, Nichols W W, Cartwright S J, MacGowan A P, Bennett P M. Sequence and analysis of the L1 metallo-β-lactamase from Xanthomonas maltophilia. Biochim Biophys Acta. 1994;1218:199–201. doi: 10.1016/0167-4781(94)90011-6. [DOI] [PubMed] [Google Scholar]
  • 33.Walsh T R, Neville W A, Haran M H, Tolson D, Payne D J, Bateson J H, MacGowan A P, Bennett P M. Nucleotide and amino acid sequences of the metallo-beta-lactamase, ImiS, from Aeromonas veronii bv. sobria. Antimicrob Agents Chemother. 1998;42:436–439. doi: 10.1128/aac.42.2.436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Woodford N, Palepou M-F I, Babini G S, Holmes B, Livermore D M. Carbapenemases of Chryseobacterium (Flavobacterium) meningosepticum: distribution of blaB and characterization of a novel metallo-β-lactamase gene, blaB3, in the type strain, NCTC 10016. Antimicrob Agents Chemother. 2000;44:1448–1452. doi: 10.1128/aac.44.6.1448-1452.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES